The biggest European pharmaceutical corporations achieved large revenues in 2005 with an average growth of around 12 percent. Aventis is the market leader in Europe, benefiting from the European enlargement with the implementation of European property rights in Easter European countries and the availability of a high-quality workforce.
Demand for pharmaceutical products is constantly growing, due to the increasing health-consciousness of consumers and ageing population. The trend towards self-medication is still on the rise.
The Biotechnology segment is about to recover as well, attracting a total investment of 4 billion USD in 2005 and 23 IPOs and anticipating growth.
Register now for a Quicktake service!
For more information call +49 211- 737-767-10 or e-mail Ed.Fantasia@mail.doc.gov